
Mesoblast Ltd (MESO)
US$ 11.914.93%
Price Chart
Key Statistics
Market Cap
$ 1.47B
P/E Ratio
0.00
Revenue (TTM)
$ 5.67M
Volume
215.21K
52W High
$ 22.00
52W Low
$ 5.78
Dividend Yield
0.00%
Beta
1.43
Technicals
50-Day MA
11.9026
200-Day MA
11.7612
52 Week High
22
52 Week Low
5.78
About MESO
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. Its proprietary regenerative medicine technology platform is.
Employees
73
Headquarters
Melbourne, VIC
CEO
Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)
Latest News
Synthesis of nickel(II)-containing meso -edited phthalocyanine derivatives - Nature
2025-03-29 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg